Contemporary Tailored Oncology Treatment of Biliary Tract Cancers
Biliary tract cancers (BTCs) are poor prognosis malignancies with limited treatment options. Capecitabine has recently emerged as an effective agent in the adjuvant setting; however, treatment of advanced disease is still limited to first-line cisplatin and gemcitabine chemotherapy. Recent global ef...
محفوظ في:
| المؤلفون الرئيسيون: | , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Wiley
2019-01-01
|
| سلاسل: | Gastroenterology Research and Practice |
| الوصول للمادة أونلاين: | http://dx.doi.org/10.1155/2019/7698786 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|